Formerly Variv Capital, this firm backs platforms that simplify complex consumer transactions and health access.
About Cometa
Cometa, formerly Variv Capital, is a Mexico City-based venture firm backing platforms that simplify complex consumer transactions and access, including healthcare, with Seed and Series A checks in the $1M to $5M range. The fund’s positioning is consumer-and-platform-oriented, with relevant healthcare surfaces including telemedicine, pharmacy and care navigation platforms, mental and consumer wellness, and B2B SaaS targeting Mexican and broader Spanish-speaking LatAm providers. Founders pursuing biotech, devices, or care delivery brick-and-mortar should look elsewhere. The right founder is a Mexican or LatAm technical or commercial operator building a consumer or prosumer platform with real engagement metrics and a path to category leadership in Mexico, with regional expansion into Colombia, Chile, and broader Spanish-speaking markets. Cometa is most useful when a founder is building toward consumer scale rather than enterprise SaaS niche, and when the product genuinely simplifies access or reduces friction in markets where incumbents are slow. Geographic advantage is the Mexico City operator network, deep familiarity with Mexican consumer behavior, and connectivity into broader LatAm Tier-1 funds and US Series A leads. Best entry is a warm intro from a portfolio founder, a Mexican operator in the ecosystem, or a regional co-investor such as Hi Ventures, Kaszek, or Dux. Lead the pitch with engagement metrics, real consumer revenue or strong willingness-to-pay evidence, and a credible regional expansion plan. AI healthcare founders should describe Spanish-language model performance, data residency under Mexican data protection law, and how clinical or operational integration cycles work. Caveats: Mexican healthcare’s payer fragmentation across IMSS, ISSSTE, and private insurance is real, and savvy investors model that complexity. Mexico’s macro and political dynamics also affect operating budgets, so founders should structure FX and treasury accordingly. Ask Cometa about reserves, prorata behavior, and which Series B and C leads have followed it into portfolio companies. Confirm fund vintage and the rebrand context from Variv, since fund continuity through rebrands deserves diligence. Reference checks with current portfolio CEOs on operating support, regional introductions, and behavior in hard rounds are particularly worth the time. Used appropriately, Cometa is a credible Mexican consumer-and-platform partner for healthcare access founders; for enterprise B2B health IT founders, the fit is narrower.
Founder reviews
Other portfolio companies
Companies in Cometa's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from Cometa? Founders only — share your honest experience (anonymous OK, moderated before publishing).